NeoGenomics expands Indica Labs partnership to scale AI-powered digital pathology

NeoGenomics (NEO) expanded its partnership with Indica Labs to deploy the HALO AP digital pathology platform across its enterprise. The cloud-based, vendor-neutral system is intended to reduce integration costs and capital investment while enabling third-party or in-house AI tools. The company expects the infrastructure to support AI-based biomarker testing as the ADC pipeline grows, and to enable future AI co-development and clinical trial collaborations. NeoGenomics has worked with Indica Labs since 2015.